S-1/A Filing

Astrana Health, Inc. CIK: 1083446 FY 2014

Filing Information

Form Type	S-1/A
Accession Number	`0001144204-15-028497`
Period End Date	20141231
Filing Date	20150507
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	ameh-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 157 Income Statement 242 Cash Flow Statement 256 Stockholders Equity 60

Balance Sheet 157 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$164.36K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$40.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.51M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.58M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.86M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.70M	shares	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$12.43K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.91M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	3.48M	shares	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	-	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$5.65K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	3.48M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.91M	shares	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$11.46K	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$1.60K	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$24.04K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.70M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$135.98K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$42.20K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$53.54K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$72.63K	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	-	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$34.61K	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$97.81K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.66M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.13M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.43M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.87M	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$144.34K	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$218.64K	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$366.29K	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$294.33K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$560.94K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$85.69K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$94.95K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$68.14K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$1.91M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.63K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	-	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$62.43K	USD	Point-in-time
Goodwill	`Goodwill`	$1.39M	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Goodwill	`Goodwill`	$33.20K	USD	Point-in-time
Goodwill	`Goodwill`	$32.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$38.68K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$211.09K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$30.98K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.64K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.02M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.22M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.48M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.96M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.56M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.45M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.37M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$950.65K	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$552.56K	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.81M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$1.58M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$444.76K	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$594.76K	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$3.18M	USD	Point-in-time
Holdback consideration	`HoldbackConsideration`	-	USD	Point-in-time
Holdback consideration	`HoldbackConsideration`	$376.24K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$159.33K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.33M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.55M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	$5.04M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	$5.34M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$2.00M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$1.10M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$1.91M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$962.98K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.45M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$120.00K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Conversion feature liability	`ConversionFeatureLiability`	$-487.63K	USD	Point-in-time
Conversion feature liability	`ConversionFeatureLiability`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$185.97K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.61M	USD	Point-in-time
Total liabilities	`Liabilities`	$16.49M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.65M	USD	Point-in-time
COMMITMENTS, CONTINGENCIES and SUBSEQUENT EVENTS (NOTES 10 and 11 )	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS, CONTINGENCIES and SUBSEQUENT EVENTS (NOTES 10 and 11 )	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock	`CommonStockValue`	$4.70K	USD	Point-in-time
Common Stock	`CommonStockValue`	$4.86K	USD	Point-in-time
Common Stock	`CommonStockValue`	$3.48K	USD	Point-in-time
Common Stock	`CommonStockValue`	$4.91K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.38M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$10.66M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$14.15M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$15.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-17.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.77M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.41M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-3.14M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.08M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.62M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.67M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$692.40K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$926.43K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$782.26K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-421.22K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.47M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-391.38K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$3.22M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$9.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$3.96M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$15.02M	USD	Point-in-time

Income Statement 242 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$2.83M	USD	1 Quarter
Net revenues	`Revenues`	$2.59M	USD	1 Quarter
Net revenues	`Revenues`	$2.53M	USD	1 Quarter
Net revenues	`Revenues`	$1.97M	USD	1 Quarter
Net revenues	`Revenues`	$2.61M	USD	1 Quarter
Net revenues	`Revenues`	$1.63M	USD	1 Quarter
Net revenues	`Revenues`	$1.66M	USD	1 Quarter
Net revenues	`Revenues`	$7.64M	USD	1 Quarter
Net revenues	`Revenues`	$10.48M	USD	Annual
Net revenues	`Revenues`	$23.40M	USD	3 Qtrs
Net revenues	`Revenues`	$1.65M	USD	1 Quarter
Net revenues	`Revenues`	$7.78M	USD	Annual
Net revenues	`Revenues`	$7.97M	USD	3 Qtrs
Net revenues	`Revenues`	$2.34M	USD	1 Quarter
Net revenues	`Revenues`	$2.84M	USD	1 Quarter
Net revenues	`Revenues`	$2.45M	USD	1 Quarter
Cost of services	`CostOfServices`	$2.03M	USD	1 Quarter
Cost of services	`CostOfServices`	$6.75M	USD	3 Qtrs
Cost of services	`CostOfServices`	$6.32M	USD	Annual
Cost of services	`CostOfServices`	$9.08M	USD	Annual
Cost of services	`CostOfServices`	$15.51M	USD	3 Qtrs
Cost of services	`CostOfServices`	$6.09M	USD	1 Quarter
Cost of services	`CostOfServices`	$2.05M	USD	1 Quarter
Cost of services	`CostOfServices`	$1.18M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.46M	USD	Annual
Gross profit	`GrossProfit`	$1.41M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.57M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.89M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$531.12K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.35M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$826.87K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.60M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.52M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.29M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.76K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$399.24K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.51K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$31.36K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$194.06K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.92K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.16K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.28K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$3.64M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$1.72M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$3.54M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$11.34M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$24.26M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$2.88M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$9.17M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$5.32M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-63.03K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-813.49K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-57.46K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.44M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.37M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.36M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.08M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-808.60K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-53.15K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-711.97K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-525.08K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-547.03K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.91M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-1.02M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-859.65K	USD	3 Qtrs
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	$-2.91M	USD	1 Quarter
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	-	USD	Annual
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	-	USD	1 Quarter
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	-	USD	1 Quarter
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	$-5.85M	USD	Annual
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	-	USD	1 Quarter
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	-	USD	1 Quarter
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	$-3.06M	USD	1 Quarter
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	-	USD	1 Quarter
Loss on change in fair value of derivative liabilities	`ChangeInFairValueOfWarrantLiabilities`	$123.84K	USD	1 Quarter
Interest expense	`InterestExpense`	$-127.49K	USD	1 Quarter
Interest expense	`InterestExpense`	$-221.24K	USD	1 Quarter
Interest expense	`InterestExpense`	$930.18K	USD	Annual
Interest expense	`InterestExpense`	$969.06K	USD	3 Qtrs
Interest expense	`InterestExpense`	$-224.04K	USD	1 Quarter
Interest expense	`InterestExpense`	$-224.91K	USD	1 Quarter
Interest expense	`InterestExpense`	$362.94K	USD	1 Quarter
Interest expense	`InterestExpense`	$-202.21K	USD	1 Quarter
Interest expense	`InterestExpense`	$184.58K	USD	1 Quarter
Interest expense	`InterestExpense`	$86.11K	USD	1 Quarter
Interest expense	`InterestExpense`	$679.18K	USD	Annual
Interest expense	`InterestExpense`	$-260.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$-178.68K	USD	1 Quarter
Interest expense	`InterestExpense`	$-170.81K	USD	1 Quarter
Interest expense	`InterestExpense`	$518.51K	USD	3 Qtrs
Interest expense	`InterestExpense`	$156.26K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	3 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-5.85M	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$358.43K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$480.57K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$6.75K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-246.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$9.48K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$455.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$28.82K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$51.74K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-37.25K	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-5.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$41.40K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$112.65K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-37.90K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.48K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-739.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$207.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-924.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$49.70K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$108.15K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-155.76K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-511.76K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-6.82M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-157.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-629.48K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-84.64K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-436.76K	USD	3 Qtrs
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.30M	USD	3 Qtrs
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-965.59K	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-982.69K	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.18M	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-702.79K	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-142.10K	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-822.98K	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.88M	USD	3 Qtrs
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-153.36K	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-839.71K	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.20M	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.42M	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.72M	USD	1 Quarter
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.53M	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$19.51K	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$7.82K	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-21.85K	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$4.00K	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$4.80K	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$800.00	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$66.65K	USD	3 Qtrs
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$31.96K	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-800.00	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$3.00K	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-31.94K	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$9.40K	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income (loss) before provision for state income tax	`StateAndLocalIncomeTaxExpenseBenefitContinuingOperations`	$-8.90M	USD	Annual
Income (loss) before provision for state income tax	`StateAndLocalIncomeTaxExpenseBenefitContinuingOperations`	$-4.54M	USD	Annual
Net loss	`ProfitLoss`	$-1.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-157.36K	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.88M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-3.20M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.16M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.01M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.39M	USD	1 Quarter
Net loss	`ProfitLoss`	$-710.61K	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.90M	USD	Annual
Net loss	`ProfitLoss`	$-1.36M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-4.56M	USD	Annual
Net loss	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-964.79K	USD	1 Quarter
Net loss	`ProfitLoss`	$-822.98K	USD	1 Quarter
Net loss	`ProfitLoss`	$-849.12K	USD	1 Quarter
Net loss	`ProfitLoss`	$-145.10K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-93.89K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-100.34K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$339.37K	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$501.50K	USD	Annual
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-119.23K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-108.15K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-183.17K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$55.83K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-90.78K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$300.14K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$79.30K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$110.04K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$629.96K	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-116.30K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$461.42K	USD	Annual
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-151.07K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.99M	USD	3 Qtrs
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.69M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.00M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-4.22M	USD	3 Qtrs
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.11M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-9.41M	USD	Annual
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.65M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-5.02M	USD	Annual
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.07M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-766.44K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-4.83M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.01M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.26M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-224.40K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-273.65K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-3.30M	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-33.09K	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	3 Qtrs
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.99M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.72M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.22M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.07M	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.43	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-2.90	USD	Annual
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-1.37	USD	Annual
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-1.44	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	3 Qtrs
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-1.13	USD	3 Qtrs
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-1.06	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.48M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.90M	shares	3 Qtrs
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.80M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.21M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.48M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.48M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.25M	shares	Annual
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.72M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.34M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.10M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.88M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.80M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.73M	shares	3 Qtrs
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.67M	shares	Annual
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.90M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.00M	shares	1 Quarter

Cash Flow Statement 256 line items

Line Item	Tag	Value	Unit	Period
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$660.89K	USD	3 Qtrs
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$660.89K	USD	3 Qtrs
Net Income (loss)	`ProfitLoss`	$-1.53M	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-157.36K	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-3.88M	USD	3 Qtrs
Net Income (loss)	`ProfitLoss`	$-3.20M	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-1.16M	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-1.01M	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-1.39M	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-710.61K	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-8.90M	USD	Annual
Net Income (loss)	`ProfitLoss`	$-1.36M	USD	3 Qtrs
Net Income (loss)	`ProfitLoss`	$-4.56M	USD	Annual
Net Income (loss)	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-964.79K	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-822.98K	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-849.12K	USD	1 Quarter
Net Income (loss)	`ProfitLoss`	$-145.10K	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$74.39K	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$64.81K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$5.76K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$399.24K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$4.51K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$31.36K	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$194.06K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$20.92K	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$19.16K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$6.28K	USD	1 Quarter
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-12.95K	USD	3 Qtrs
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$23.00K	USD	1 Quarter
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$24.78K	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	3 Qtrs
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	$49.79K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$13.03K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.16M	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$45.29K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.06M	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$-22.20K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$1.13M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$60.19K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.10M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$156.55K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$169.34K	USD	3 Qtrs
Amortization of financing costs	`AdjustmentForAmortization`	$89.16K	USD	Annual
Amortization of financing costs	`AdjustmentForAmortization`	$91.96K	USD	3 Qtrs
Amortization of financing costs	`AdjustmentForAmortization`	$255.40K	USD	Annual
Amortization of financing costs	`AdjustmentForAmortization`	$9.51K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$25.96K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$76.89K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$136.75K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$288.58K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$15.17K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$19.41K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$670.70K	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	3 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-5.85M	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$358.43K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$480.57K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-72.92K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-414.62K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$850.82K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.13K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$548.90K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$158.63K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$12.43K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-4.05K	USD	Annual
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$12.06K	USD	1 Quarter
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-5.50K	USD	Annual
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-80.30K	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-18.01K	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$22.44K	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-11.34K	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-8.48K	USD	3 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-2.74K	USD	3 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-19.08K	USD	Annual
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$23.67K	USD	Annual
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-12.39K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-6.12K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$102.69K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-7.02K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$27.70K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.95K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$626.31K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$84.71K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$764.21K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$50.38K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$606.97K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$455.74K	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-114.92K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-831.84K	USD	3 Qtrs
Due to officers	`IncreaseDecreaseInDueToOfficersAndStockholdersCurrent`	-	USD	Annual
Due to officers	`IncreaseDecreaseInDueToOfficersAndStockholdersCurrent`	$-12.40K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.48M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$652.32K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-178.55K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$57.96K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-854.39K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-8.89K	USD	1 Quarter
Acquisitions, net of $660,893 of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.08M	USD	3 Qtrs
Acquisitions, net of $660,893 of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$229.50K	USD	3 Qtrs
Acquisitions, net of $660,893 of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$250.00K	USD	Annual
Acquisitions, net of $660,893 of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$-14.11K	USD	Annual
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$45.80K	USD	Annual
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.93K	USD	Annual
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$37.21K	USD	3 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.66K	USD	3 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.20K	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.23K	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$438.88K	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-272.93K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-12.23K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.20K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-240.16K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-31.68K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.67M	USD	3 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$220.00K	USD	Annual
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$880.00K	USD	Annual
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$100.00K	USD	1 Quarter
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$2.00M	USD	3 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	-	USD	1 Quarter
Proceeds from stock option exercise	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Proceeds from stock option exercise	`ProceedsFromStockOptionsExercised`	$15.75K	USD	Annual
Payment of note payable	`RepaymentsOfNotesPayable`	$530.00K	USD	Annual
Payment of note payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$1.00M	USD	3 Qtrs
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$2.29M	USD	3 Qtrs
Repayment of line of credit	`RepaymentsOfLinesOfCredit`	-	USD	1 Quarter
Repayment of line of credit	`RepaymentsOfLinesOfCredit`	$2.81M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.00M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$731.75K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$730.00K	USD	Annual
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$459.76K	USD	3 Qtrs
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$813.58K	USD	3 Qtrs
Contributions by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	3 Qtrs
Contributions by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	$586.11K	USD	3 Qtrs
Proceeds from notes and line of credit payable	`ProceedsFromNotesAndLineOfCreditPayable`	$7.00M	USD	1 Quarter
Proceeds from notes and line of credit payable	`ProceedsFromNotesAndLineOfCreditPayable`	$2.81M	USD	Annual
Proceeds from notes and line of credit payable	`ProceedsFromNotesAndLineOfCreditPayable`	-	USD	1 Quarter
Proceeds from notes and line of credit payable	`ProceedsFromNotesAndLineOfCreditPayable`	$594.76K	USD	Annual
Payment of medical clinic acquisition notes payable	`PaymentOfMedicalClinicAcquisitionNotesPayable`	-	USD	1 Quarter
Payment of medical clinic acquisition notes payable	`PaymentOfMedicalClinicAcquisitionNotesPayable`	$256.00K	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$240.00K	USD	Annual
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$240.00K	USD	3 Qtrs
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	-	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$200.00K	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$600.00K	USD	3 Qtrs
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$400.00K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$950.00K	USD	Point-in-time
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$303.15K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$104.42K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$258.15K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$232.68K	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$20.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$10.00K	USD	3 Qtrs
Cash payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	$514.14K	USD	3 Qtrs
Cash payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	-	USD	Annual
Cash payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	$98.25K	USD	1 Quarter
Cash payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	-	USD	3 Qtrs
Cash payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	$707.91K	USD	Annual
Cash payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$5.40M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.14M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.51M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$986.10K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$100.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.03M	USD	Annual
NET INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$120.28K	USD	3 Qtrs
NET INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.38M	USD	1 Quarter
NET INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$413.13K	USD	3 Qtrs
NET INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.01M	USD	Annual
NET INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-81.75K	USD	1 Quarter
NET INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$274.68K	USD	Annual
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$164.36K	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$164.36K	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Interest paid	`InterestPaid`	$160.79K	USD	Annual
Interest paid	`InterestPaid`	$247.47K	USD	Annual
Interest paid	`InterestPaid`	$518.51K	USD	3 Qtrs
Interest paid	`InterestPaid`	$18.06K	USD	1 Quarter
Interest paid	`InterestPaid`	$514.22K	USD	3 Qtrs
Interest paid	`InterestPaid`	$84.72K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$19.51K	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$18.59K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$43.89K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$9.40K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$3.82K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$9.76K	USD	Annual
Acquisition related holdback liability consideration	`AcquisitionRelatedHoldbackLiabilityConsideration`	$376.24K	USD	3 Qtrs
Acquisition related holdback liability consideration	`AcquisitionRelatedHoldbackLiabilityConsideration`	-	USD	3 Qtrs
Convertible note warrant	`ConvertibleNoteWarrant`	$13.32K	USD	3 Qtrs
Convertible note warrant	`ConvertibleNoteWarrant`	$487.62K	USD	3 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$509.89K	USD	Annual
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$578.15K	USD	3 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	Annual
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$125.00K	USD	3 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$132.00K	USD	3 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$101.82K	USD	3 Qtrs
Acquisition related consideration fair value of membership interests issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$113.10K	USD	Annual
Acquisition related consideration fair value of membership interests issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	3 Qtrs
Acquisition related consideration fair value of membership interests issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	3 Qtrs
Acquisition related deferred tax liabilities	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	-	USD	3 Qtrs
Acquisition related deferred tax liabilities	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$172.95K	USD	3 Qtrs
Warrants issued in connection with convertible note issuance	`WarrantsIssuedInConnectionWithNotesPayable`	$6.72K	USD	1 Quarter
Warrants issued in connection with convertible note issuance	`WarrantsIssuedInConnectionWithNotesPayable`	$50.94K	USD	Annual
Warrants issued in connection with convertible note issuance	`WarrantsIssuedInConnectionWithNotesPayable`	$387.35K	USD	Annual
Warrants issued in connection with convertible note issuance	`WarrantsIssuedInConnectionWithNotesPayable`	-	USD	1 Quarter
Shares issuable and issued for note payable financing fees	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	$45.00K	USD	Annual
Shares issuable and issued for note payable financing fees	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	$45.00K	USD	1 Quarter
Shares issuable and issued for note payable financing fees	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	$198.94K	USD	Annual
Shares issuable and issued for note payable financing fees	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	-	USD	1 Quarter
NNA term loan discount	`DiscountOnTermLoan`	-	USD	1 Quarter
NNA term loan discount	`DiscountOnTermLoan`	$1.25M	USD	1 Quarter
Notes payable issued in connection with medical clinic acquisitions	`NotesIssued1`	-	USD	Annual
Notes payable issued in connection with medical clinic acquisitions	`NotesIssued1`	$299.90K	USD	Annual
Settlement of stock issuable liability with issuance of shares	`SettlementOfStockIssuableLiabilityWithIssuanceOfShares`	$159.33K	USD	Annual
Settlement of stock issuable liability with issuance of shares	`SettlementOfStockIssuableLiabilityWithIssuanceOfShares`	-	USD	Annual
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	-	USD	1 Quarter
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	$864.30K	USD	Annual
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	-	USD	Annual
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	$51.75K	USD	1 Quarter
Fair value of warrant liabilities	`FairValueOfWarrantLiabilities`	$2.35M	USD	1 Quarter
Fair value of warrant liabilities	`FairValueOfWarrantLiabilities`	-	USD	1 Quarter
NNA shares issuance discount	`DiscountOnSharesIssuance`	$1.10M	USD	1 Quarter
NNA shares issuance discount	`DiscountOnSharesIssuance`	-	USD	1 Quarter
Warrants and derivative reclassified from liabilities to stockholders' deficit	`ReclassificationOfWarrantLiabilitiesToEquity`	$6.63M	USD	Annual
Warrants and derivative reclassified from liabilities to stockholders' deficit	`ReclassificationOfWarrantLiabilitiesToEquity`	-	USD	Annual
Shares issued for services	`SharesIssuableForServices`	$159.33K	USD	Annual
Shares issued for services	`SharesIssuableForServices`	-	USD	Annual

Stockholders Equity 60 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-421.22K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.47M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-391.38K	USD	Point-in-time
Share issuance/cancellation	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	$1.97M	USD	Annual
Share issuance/cancellation	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	$730.98K	USD	Annual
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$132.00K	USD	3 Qtrs
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$50.94K	USD	Annual
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$510.64K	USD	Annual
Contributions by non-controlling interest	`ContributionByNoncontrollingInterest`	$586.11K	USD	3 Qtrs
Shares issued in NNA financing	`StockIssuedDuringPeriodValueForFinancing`	$868.24K	USD	1 Quarter
8% notes share conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$51.75K	USD	1 Quarter
Distribution to non-controlling interest	`DistributionToNonControllingInterest`	$-200.00K	USD	1 Quarter
Distribution to non-controlling interest	`DistributionToNonControllingInterest`	$-600.00K	USD	3 Qtrs
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$113.10K	USD	Annual
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	3 Qtrs
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$60.19K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.13M	USD	3 Qtrs
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$10.00K	USD	3 Qtrs
Shares reconveyed in connection with termination of AHI transaction	`StockholdersEquityOther`	-	USD	Annual
Shares reconveyed in connection with termination of AHI transaction (in shares)	`StockholdersEquityOtherShares`	50,000.00	shares	Annual
Distributions to non-controlling interest shareholder	`MinorityInterestPeriodIncreaseDecrease`	$-240.00K	USD	Annual
Distributions to non-controlling interest shareholder	`MinorityInterestPeriodIncreaseDecrease`	$-400.00K	USD	Annual
Reclassification of warrant and derivative liabilities	`AdjustmentsToAdditionalPaidInCapitalWarrantAndDerivativeLiabilities`	$6.63M	USD	Annual
Unvested stock-based compensation classified as prepaid	`AdjustmentToAdditionalPaidInCapitalShareBasedCompensationNonVestedSharesRequisiteServicePeriodRecognition`	$333.84K	USD	Annual
Unvested stock-based compensation classified as prepaid	`AdjustmentToAdditionalPaidInCapitalShareBasedCompensationNonVestedSharesRequisiteServicePeriodRecognition`	$-616.01K	USD	Annual
Issuance of stock options for stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$709.98K	USD	Annual
Issuance of stock options for stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$1.25M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$15.75K	USD	Annual
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	0.00	shares	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	0.00	shares	Annual
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	0.00	shares	3 Qtrs
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	7,500.00	shares	Annual
Issuance of common stock for loan fees	`StockIssuedDuringPeriodValueOther`	$45.00K	USD	Annual
Shares issued in connection with convertible notes redemption	`StockIssuedDuringPeriodValueConvertibleNotesRedemption`	$864.30K	USD	Annual
Fair value of embedded conversion feature reacquired in connection with convertible notes redemption	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$509.89K	USD	Annual
Shares issued in connection with private placement offering	`StockIssuedDuringPeriodValueNewIssues`	$730.00K	USD	Annual
Net (loss) income	`ProfitLoss`	$-1.53M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-157.36K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-3.88M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-3.20M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.16M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.01M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.39M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-710.61K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-8.90M	USD	Annual
Net (loss) income	`ProfitLoss`	$-1.36M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-4.56M	USD	Annual
Net (loss) income	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-964.79K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-822.98K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-849.12K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-145.10K	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-421.22K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.47M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-391.38K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.